Comparable COVID‐19 outcomes with current use of GLP‐1 receptor agonists, DPP‐4 inhibitors or SGLT‐2 inhibitors among patients with diabetes who tested …

SB Israelsen, A Pottegård, H Sandholdt… - Diabetes, Obesity …, 2021 - Wiley Online Library
Incretin‐based therapies, glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and
dipeptidyl peptidase‐4 inhibitors (DPP‐4i), have been hypothesized to exert beneficial effects on …

Improved survival among hospitalized patients with coronavirus disease 2019 (COVID-19) treated with remdesivir and dexamethasone. A nationwide population …

…, M Helleberg, C Holm, SB Israelsen… - Clinical Infectious …, 2021 - academic.oup.com
Background There are limited data on outcomes of moderate to severe coronavirus disease
2019 (COVID-19) among patients treated with remdesivir and dexamethasone in a real-…

[PDF][PDF] Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020

SB Israelsen, KT Kristiansen, B Hindsberger… - Dan Med …, 2020 - content.ugeskriftet.dk
METHODS This retrospective case series included adults 18 years of age or older with a
new-onset pulmonary infiltrate and confirmed SARS-CoV-2 infection who were consecutively …

Venous thromboembolism and major bleeding in patients with coronavirus disease 2019 (COVID-19): a nationwide, population-based cohort study

…, LH Omland, LF Lundbo, SB Israelsen… - Clinical Infectious …, 2021 - academic.oup.com
Background Venous thromboembolism (VTE) is a potentially fatal complication of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and thromboprophylaxis …

[HTML][HTML] The association of low vitamin K status with mortality in a cohort of 138 hospitalized patients with COVID-19

A Linneberg, FB Kampmann, SB Israelsen… - Nutrients, 2021 - mdpi.com
It has recently been hypothesized that vitamin K could play a role in COVID-19. We aimed to
test the hypotheses that low vitamin K status is a common characteristic of patients …

[HTML][HTML] First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study

…, TK Fischer, OS Søgaard, SB Israelsen… - BMC Infectious …, 2021 - Springer
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its
associated disease coronavirus disease 2019 (COVID-19), is a worldwide emergency. …

[HTML][HTML] Proton pump inhibitor use is not strongly associated with SARS-CoV-2 related outcomes: a nationwide study and meta-analysis

SB Israelsen, MT Ernst, A Lundh, LF Lundbo… - Clinical …, 2021 - Elsevier
Background & Aims Proton pump inhibitor (PPI) use has been associated with increased
risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe …

[HTML][HTML] Prediction of respiratory failure and mortality in COVID-19 patients using long pentraxin PTX3

…, L Pedersen, S Bastrup Israelsen… - Journal of Innate …, 2022 - karger.com
The course of COVID-19 is unpredictable, ranging from asymptomatic to respiratory failure
and death. Prognostic biomarkers are urgently needed. We hypothesized that long pentraxin …

[HTML][HTML] The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection

…, CF Christiansen, SB Israelsen… - European …, 2022 - Eur Respiratory Soc
Background Immunosuppression may worsen severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection. We conducted a nationwide cohort study of the effect of …

Predominance of hospital-acquired bloodstream infection in patients with Covid-19 pneumonia

AL Engsbro, SB Israelsen, M Pedersen… - Infectious …, 2020 - Taylor & Francis
To the editor, Recently, in this journal, a study on disease progression in hospitalized Covid-19
patients was reported [1]. We here contribute with data on the risk for hospitalacquired …